Review
doi: 10.1016/s0896-6273(03)00195-8.
Finding the intracellular signaling pathways affected by mood disorder treatments
Affiliations
- PMID: 12718851
- DOI: 10.1016/s0896-6273(03)00195-8
Item in Clipboard
Review
Finding the intracellular signaling pathways affected by mood disorder treatments
Neuron.
.
Free article
Abstract
Postmortem and brain imaging studies have revealed structural changes and cell loss in cortico-limbic regions of the brain in bipolar disorder and major depression. Consistent with these findings, mood stabilizers such as lithium ion and valproic acid, which are used to treat bipolar disorder, as well as antidepressants and electroconvulsive therapy have recently been shown to activate interconnected intracellular signaling pathways that promote neurogenesis and synaptic plasticity. These insights should assist in understanding the pathophysiology of severe mood disorders as well as aid in the development of more effective treatments.
Similar articles
-
Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants.Psychosom Med. 1999 Sep-Oct;61(5):599-617. doi: 10.1097/00006842-199909000-00004. Psychosom Med. 1999. PMID: 10511011 Review.
-
Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.Ann N Y Acad Sci. 2003 Nov;1003:273-91. doi: 10.1196/annals.1300.017. Ann N Y Acad Sci. 2003. PMID: 14684452 Review.
-
A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?Mol Neurobiol. 2011 Dec;44(3):407-19. doi: 10.1007/s12035-011-8210-4. Epub 2011 Oct 5. Mol Neurobiol. 2011. PMID: 21983961 Review.
-
Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.Psychopharmacol Bull. 2001 Spring;35(2):5-49. Psychopharmacol Bull. 2001. PMID: 12397885 Review.
-
[Mood stabilizers--past, present and future].Neuropsychopharmacol Hung. 2008 Mar;10(1):31-42. Neuropsychopharmacol Hung. 2008. PMID: 18771018 Review. Hungarian.
Cited by
-
Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease.Neuropsychopharmacology. 2012 Jul;37(8):1934-44. doi: 10.1038/npp.2012.40. Epub 2012 Apr 11. Neuropsychopharmacology. 2012. PMID: 22491352 Free PMC article.
-
Two polygenic mouse models of major depressive disorders identify TMEM161B as a potential biomarker of disease in humans.Neuropsychopharmacology. 2024 Jun;49(7):1129-1139. doi: 10.1038/s41386-024-01811-8. Epub 2024 Feb 7. Neuropsychopharmacology. 2024. PMID: 38326457
-
Age-modulated association between prefrontal NAA and the BDNF gene.Int J Neuropsychopharmacol. 2013 Jul;16(6):1185-93. doi: 10.1017/S1461145712001204. Epub 2012 Dec 20. Int J Neuropsychopharmacol. 2013. PMID: 23253771 Free PMC article.
-
MAPK signaling determines anxiety in the juvenile mouse brain but depression-like behavior in adults.PLoS One. 2012;7(4):e35035. doi: 10.1371/journal.pone.0035035. Epub 2012 Apr 18. PLoS One. 2012. PMID: 22529971 Free PMC article.
-
Lithium induces autophagy by inhibiting inositol monophosphatase.J Cell Biol. 2005 Sep 26;170(7):1101-11. doi: 10.1083/jcb.200504035. J Cell Biol. 2005. PMID: 16186256 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
